Oxidase uncoupling in heme monooxygenases: Human cytochrome P450 CYP3A4 in Nanodiscs

被引:47
|
作者
Grinkova, Yelena V.
Denisov, Ilia G.
McLean, Mark A.
Sligar, Stephen G.
机构
[1] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
关键词
Cytochrome P450; CYP3A4; Nanodiscs; P450; mechanism; Uncoupling; Oxidase pathway; LIVER MICROSOMAL CYTOCHROME-P-450; HIGH-VALENT IRON; OXYGEN ACTIVATION; LIGAND-BINDING; 3A4; COOPERATIVITY; KINETICS; HYDROXYLATION; INTERMEDIATE; OXIDATIONS;
D O I
10.1016/j.bbrc.2012.12.072
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The normal reaction mechanism of cytochrome P450 operates by utilizing two reducing,equivalents to reduce atmospheric dioxygen, producing one molecule of water and an oxygenated product in an overall stoichiometry of 2 electrons:1 dioxygen:1 product. However, three alternate unproductive pathways exist where the intermediate iron-oxygen states in the catalytic cycle can yield reduced oxygen products without substrate metabolism. The first involves release of superoxide from the oxygenated intermediate while the second occurs after input of the second reducing equivalent. Superoxide rapidly dismutates and hence both processes produce hydrogen peroxide that can be cytotoxic to the organism. In both cases, the formation of hydrogen peroxide involves the same overall stoichiometry as oxygenases catalysis. The key step in the catalytic cycle of cytochrome P450 involves scission of the oxygen-oxygen bond of atmospheric dioxygen to produce a higher valent iron-oxo state termed "Compound I". This intermediate initiates a radical reaction in the oxygenase pathway but also can uptake two additional reducing equivalents from reduced pyridine nucleotide (NADPH) and the flavoprotein reductase to produce a second molecule of water. This non-productive decay of Compound I thus yields an overall oxygen to NADPH ratio of 1:2 and does not produce hydrocarbon oxidation. This water uncoupling reaction provides one of a limited means to study the reactivity of the critical Compound I intermediate in P450 catalysis. We measured simultaneously the rates of NADPH and oxygen consumption as a function of substrate concentration during the steady-state hydroxylation of testosterone catalyzed by human P450 CYP3A4 reconstituted in Nanodiscs. We discovered that the "oxidase" uncoupling pathway is also operating in the substrate free form of the enzyme with rate of this pathway substantially increasing with the first substrate binding event. Surprisingly, a large fraction of the reducing equivalents used by the P450 system is wasted in this oxidase pathway. In addition, the overall coupling with testosterone and bromocryptine as substrates is significantly higher in the presence of anionic lipids, which is attributed to the changes in the redox potential of CYP3A4 and reductase. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1223 / 1227
页数:5
相关论文
共 50 条
  • [1] Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in Nanodiscs
    Grinkova, Yelena V.
    Denisov, Ilia G.
    Sligar, Stephen G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 398 (02) : 194 - 198
  • [2] Flexible Structure of Cytochrome P450: Promiscuity of Ligand Binding in the CYP3A4 Heme Pocket
    Ohkura, Kazuto
    Kawaguchi, Yuki
    Watanabe, Yasuko
    Masubuchi, Yasuhiro
    Shinohara, Yasuo
    Hori, Hitoshi
    ANTICANCER RESEARCH, 2009, 29 (03) : 935 - 942
  • [3] Grapefruit juice furanocoumarins and P450 cytochrome CYP3A4
    Cancalon, Paul F.
    Haun, Carl
    PROCEEDINGS OF THE 119TH ANNUAL MEETING OF THE FLORIDA STATE HORTICULTURAL SOCIETY, 2006, 119 : 358 - 360
  • [4] Changes in Drug Metabolizing Enzyme Cytochrome P450 CYP3A4 Activities Due to Polymorphisms in Human Cytochrome P450 Oxidoreductase
    Parween, Shaheena
    Udhane, Sameer S.
    Pandey, Amit V.
    FASEB JOURNAL, 2019, 33
  • [5] Prosubstrates of CYP3A4, the major human hepatic cytochrome P450 - Transformation into substrates by other P450 isoforms
    Stresser, DM
    Kupfer, D
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1861 - 1871
  • [6] Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213
    Denisov, Ilia G.
    Grinkova, Yelena, V
    Nandigrami, Prithviraj
    Shekhar, Mrinal
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2019, 58 (10) : 1411 - 1422
  • [7] Multiple in silico models for the inhibition of cytochrome P450 (CYP3A4)
    Moda, Tiago
    Meneghello, Raphael
    Andricopulo, Adriano
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [8] New fluorescent probes for Cytochrome P450 3A4 (CYP3A4)
    Chougnet, Antoinette
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2007, 12 (SUPPL 1): : S55 - S55
  • [9] Cytochrome P450 monooxygenases
    Wong, LL
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (02) : 263 - 268
  • [10] Metabolic activation and cytochrome P450 inhibition of piperlonguminine mediated by CYP3A4
    Chi, Yuqian
    Zhu, Xiaoliang
    Chen, Yaxuan
    Li, Xin
    Jiang, Ziyi
    Jian, Xiaoyang
    Lian, Mengyuan
    Wu, Xiaodi
    Wang, Lei
    Sun, Mengmeng
    Shi, Xiaowei
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 268